Alzheimer’s: New blood biomarker could predict risk of cognitive decline
![](https://post.medicalnewstoday.com/wp-content/uploads/sites/3/2023/06/blood_biomarker_Stocksy_txp6fdeb301Mbi300_Medium_3593393_Thumb.jpg)
A new study suggests that astrocytes, a type of brain cell, are important for connecting amyloid-β with the early stages of tau pathology, which could change how we define early Alzheimer's disease.